Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9

被引:12
|
作者
Haupt, Amanda [1 ]
Grancharova, Tanya [1 ]
Arakaki, Joy [1 ]
Fuqua, Margaret A. [1 ]
Roberts, Brock [1 ]
Gunawardane, Ruwanthi N. [1 ]
机构
[1] Allen Inst Cell Sci, Seattle, WA 98109 USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2018年 / 138期
关键词
Genetics; Issue; 138; Stem Cells; hiPSC; Molecular Biology; CRISPR; Cas9; Genome Engineering; Gene Knock-in; Gene Tagging; Fluorescent Protein; WEB TOOL; GENOME; CAS9; CHALLENGES; GENERATION; NUCLEASES; CHOPCHOP; DELIVERY; TALENS; ZFNS;
D O I
10.3791/58130
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A protocol is presented for generating human induced pluripotent stem cells (hiPSCs) that express endogenous proteins fused to in-frame N- or C-terminal fluorescent tags. The prokaryotic CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeats/CRISPR-associated 9) may be used to introduce large exogenous sequences into genomic loci via homology directed repair (HDR). To achieve the desired knock-in, this protocol employs the ribonucleoprotein (RNP)-based approach where wild type Streptococcus pyogenes Cas9 protein, synthetic 2-part guide RNA (gRNA), and a donor template plasmid are delivered to the cells via electroporation. Putatively edited cells expressing the fluorescently tagged proteins are enriched by fluorescence activated cell sorting (FACS). Clonal lines are then generated and can be analyzed for precise editing outcomes. By introducing the fluorescent tag at the genomic locus of the gene of interest, the resulting subcellular localization and dynamics of the fusion protein can be studied under endogenous regulatory control, a key improvement over conventional overexpression systems. The use of hiPSCs as a model system for gene tagging provides the opportunity to study the tagged proteins in diploid, nontransformed cells. Since hiPSCs can be differentiated into multiple cell types, this approach provides the opportunity to create and study tagged proteins in a variety of isogenic cellular contexts.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Focused ultrasound and microbubble-mediated delivery of CRISPR-Cas9 ribonucleoprotein to human induced pluripotent stem cells
    Hazel, Kyle
    Singh, Davindra
    He, Stephanie
    Guertin, Zakary
    Husser, Mathieu C.
    Helfield, Brandon
    MOLECULAR THERAPY, 2025, 33 (03) : 986 - 996
  • [42] FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
    Caillaud, Amandine
    Leveque, Antoine
    Thedrez, Aurelie
    Girardeau, Aurore
    Canac, Robin
    Bray, Lise
    Baudic, Manon
    Barc, Julien
    Gaborit, Nathalie
    Lamirault, Guillaume
    Gardie, Betty
    Idriss, Salam
    Rimbert, Antoine
    May, Cedric Le
    Cariou, Bertrand
    Si-Tayeb, Karim
    STAR PROTOCOLS, 2022, 3 (04):
  • [43] Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells
    Petazzi, Paolo
    Torres-Ruiz, Raul
    Fidanza, Antonella
    Roca-Ho, Heleia
    Gutierrez-Aguera, Francisco
    Castano, Julio
    Rodriguez-Perales, Sandra
    Diaz de la Guardia, Rafael
    Lopez-Millan, Belen
    Bigas, Anna
    Forrester, Lesley M.
    Bueno, Clara
    Menendez, Pablo
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 20 : 196 - 204
  • [44] An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
    Xie, Yifang
    Wang, Daqi
    Lan, Feng
    Wei, Gang
    Ni, Ting
    Chai, Renjie
    Liu, Dong
    Hu, Shijun
    Li, Mingqing
    Li, Dajin
    Wang, Hongyan
    Wang, Yongming
    SCIENTIFIC REPORTS, 2017, 7
  • [45] Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells
    Kondrashov, Alexander
    Minh Duc Hoang
    Smith, James G. W.
    Bhagwan, Jamie R.
    Duncan, Gary
    Mosqueira, Diogo
    Munoz, Maria Barbadillo
    Vo, Nguyen T. N.
    Denning, Chris
    STEM CELLS AND DEVELOPMENT, 2018, 27 (06) : 391 - 404
  • [46] Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Ge, Ning
    Liu, Min
    Li, Rui
    Allen, Nicholas M.
    Galvin, Joseph
    Shen, Sanbing
    O'Brien, Timothy
    Prendiville, Terence W.
    STEM CELL REVIEWS AND REPORTS, 2023, 19 (8) : 2774 - 2789
  • [47] Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
    Antao, Ainsley Mike
    Karapurkar, Janardhan Keshav
    Lee, Dong Ryul
    Kim, Kye-Seong
    Ramakrishna, Suresh
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 : 3649 - 3665
  • [48] Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells
    Chapman, Karen M.
    Medrano, Gerardo A.
    Jaichander, Priscilla
    Chaudhary, Jaideep
    Waits, Alexandra E.
    Nobrega, Marcelo A.
    Hotaling, James M.
    Ober, Carole
    Hamra, F. Kent
    CELL REPORTS, 2015, 10 (11): : 1828 - 1835
  • [49] Generation of NPHP1 knockout human pluripotent stem cells by a practical biallelic gene deletion strategy using CRISPR/Cas9 and ssODN
    Nakano, Yuta
    Susa, Koichiro
    Yanagi, Tomoki
    Hiraoka, Yuichi
    Suzuki, Takefumi
    Mori, Takayasu
    Ando, Fumiaki
    Mandai, Shintaro
    Fujiki, Tamami
    Rai, Tatemitsu
    Uchida, Shinichi
    Sohara, Eisei
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2022, 58 (02) : 85 - 95
  • [50] Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human- induced pluripotent stem cells
    Pandey, Priyanka
    Zhang, Nanyan
    Curtis, Brian R.
    Newman, Peter J.
    Denomme, Gregory A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (19) : 9340 - 9349